
View larger version (40K):
[in a new window]
|
Fig. 2. Actively migrating cells suppress apoptosis induction by camptothecin and Trail. (A) Representative micrograph of Trail-treated, fixed and DAPI stained T98G cells. Arrows identify cells scored as apoptotic. (B) SF767 and T98G cells were plated onto laminin-(LAM, 10 µg/ml) or 0.1% BSA-coated slides in the migration assay format and allowed to migrate for 16 hours. Cells were treated with 1 µM camptothecin for 24 hours or 100 ng/ml Trail for 16 hours, fixed and stained with DAPI. Cells in rim and core were scored for total and apoptotic cells. Values represent the mean and standard deviation of five replicate measurements. Significance with unpaired Student's t test: *P<0.001 versus rim on laminin; **P<0.01 versus rim on laminin. (C) Differential sensitivity to apoptosis is not overcome at high concentrations of cytotoxic agent. SF767 and T98G cells were plated on laminin-(10 µg/ml) coated slides in the migration assay format and allowed to migrate for 24 hours. Cells were treated with the specified concentration of camptothecin or Trail as described in Materials and Methods, fixed and DAPI stained. Cells in the rim and core were scored for total and apoptotic cells. Values represent the mean and standard deviation of four replicate measurements. (D) Camptothecin treatment generates activated caspase 3. SF767 cells in the migration assay format were treated with 1 µM camptothecin as described in Materials and Methods, fixed, stained with DAPI and immunocytochemistry for activated caspase 3 performed. Arrows show cells with condensed fragmented chromatin and positive staining for caspase 3. Bar in A and D, 5 µm.
|